Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent

DSpace/Manakin Repository

Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent
 
Leufkens, Hubert G.
(2022) Journal of Clinical Epidemiology, volume 142, pp. 258 - 260
(Comment)
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
 
Keywords: Epidemiology
DOI: https://doi.org/10.1016/j.jclinepi.2021.10.026
ISSN: 0895-4356
(Peer reviewed)
 
 
See more statistics about this item